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Introduction . Chronic pancreatitis leads to destruction o f  pancreatic parenchym and ductal structures. Pain management in 
chronic pancreatitis is often difficult and frustrating. Nociception o f  pancreatic origin can reach the CNS along two pathways: from 
afferent fibers o f  the pancreas via the greater and lesser thoracic splanchnic nerves and from innervation o f  the parietal peritoneum 
via the phrenic nerves and lower six intercostal and subcostal nerves. Denervation can by achieved at different levels. The results o f  
coeliac plexus block are limitted (I) and not without risks (2). Interpleural analgesia has shown to be effective with a striking long 
pain-free period (3). With these methods w e  had the following strategy for pain management in chronic pancreatitis. Medical 
therapy, containing paracetamol, NSAID’s and meperidine was initially tried. In case of insufficient pain relief interpleural analgesia 
was performed. When intractable pain reoccurred immediately after removal o f  the interpleural catheter an intrathecal catheter was  
inserted with continuous administration o f  a morphine and low dose bupivacaine admixture (4).
M ethods . Ten patients with chronic pancreatitis were treated according to this strategy. All patients experienced inadequate pain 
relief after medication (paracetamol, NSAID's, meperidine)» An interpleural catheter was inserted following the guidelines o f  
Reiestad (3). When intolerable pain reoccurred a intrathecal was inserted at an interspace between the second and fourth lumbar 
vertebra and advandced to T7-10. The initial intrathecal daily morphine dose was 0.0017 o f  the current daily meperidine dose. D ose  
adjustments o f  the intrathecal infusion rate were made when pain relief was inadequate or side effects occurred. The daily intrathecal 
bupivacaine dose was kept below 30 mg.
Results . Eight patients underwent a surgical drainage procedure, also without pain relief after a follow up period o f  three months. 
Tw o patients died because o f  surgical complications. Nine patients had successful interpleural analgesia during the period the 
catheter was in situ. Only one patient had a pain free period o f  four months after the interpleural catheter was removed. There were no 
side effects o f  interpleural analgesia. Five patients received intrathecal morphine and bupivacaine, three through external pumps, and 
two through implanted Medtronic® synchromed pumps. A ll  patients had satisfactory pain relief during the intrathecal infusion 
period. One patient with an external pump got a bacterial meningitis seven weeks after catheter placement. The pain relief in the two 
patients with an implanted pump with a follow up o f  over half  a year was excellent.
Discussion . A reason for the immediately reoccurrence o f  pain after removal o f  the interpleural catheter compared with Reiestad 
(3) could be a different stage o f  the disease in our patients. Long-term intrathecal analgesia with an opioid plus bupivacaine 
admixture is successful in the management o f  intractable cancer pain. An advantage is, that it is a reversible technique. The risk o f  
infection can by reduced by using an implantable infusion system. We conclude, that long-term intrathecal morphine/bupivacaine i i  
an alternative for surgical and neuroablative procedures for pain management in chronic pancreatitis. However the numbers o f  
patients, treated with intrathecal morphine/bupivacaine are limited (n=5), long-term results remain speculative.
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